QSS
ALXN

Quantitative Systematic Strategies’s Alexion Pharmaceuticals ALXN Stock Holding History

Quantitative Systematic Strategies’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,095
Closed -$752K – 437
2021
Q2 		$752K Sell
4,095
-5,645
-58% -$969K 0.26% 128
2021
Q1 		$1.49M Buy
9,740
+5,869
+152% +$908K 0.23% 138
2020
Q4 		$605K Buy
+3,871
New +$497K 0.09% 350
2019
Q3 		– Sell
-2,192
Closed -$287K – 625
2019
Q2 		$287K Buy
+2,192
New +$283K 0.05% 341
2018
Q3 		– Sell
-2,464
Closed -$306K – 850
2018
Q2 		$306K Sell
2,464
-850
-26% -$99.3K 0.06% 459
2018
Q1 		$369K Buy
3,314
+861
+35% +$103K 0.08% 400
2017
Q4 		$293K Buy
2,453
+114
+5% +$13.9K 0.07% 393
2017
Q3 		$328K Sell
2,339
-968
-29% -$132K 0.09% 313
2017
Q2 		$405K Buy
3,307
+1,384
+72% +$161K 0.1% 271
2017
Q1 		$233K Sell
1,923
-1,075
-36% -$139K 0.07% 300
2016
Q4 		$370K Sell
2,998
-382
-11% -$46.7K 0.15% 231
2016
Q3 		$406K Sell
3,380
-6,343
-65% -$816K 0.15% 218
2016
Q2 		$1.11M Buy
+9,723
New +$1.38M 0.52% 24
2015
Q3 		– Sell
-3,393
Closed -$604K – 566
2015
Q2 		$604K Sell
3,393
-3,036
-47% -$524K 0.13% 259
2015
Q1 		$1.15M Buy
6,429
+4,166
+184% +$754K 0.31% 101
2014
Q4 		$419K Buy
+2,263
New +$419K 0.17% 181

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Quantitative Systematic Strategies's ALXN Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 4,095 shares — an estimated $752K sold.

Quantitative Systematic Strategies first reported a position in ALXN in Q4 2014 and held it in 16 quarters. The position peaked at $1.49M in Q1 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 4,095 Alexion Pharmaceuticals shares in Q3 2021, an estimated $752K.
  • Quantitative Systematic Strategies first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 16 quarters.
  • Quantitative Systematic Strategies's Alexion Pharmaceuticals position peaked at $1.49M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.